Rawcliffe Adrian (CIK 0001555851)

Latest company ownership

Shares held
44,327
Last filed at
Jan 17, 2025
Confidence Score
49.9
2025Q4
Confidence Score History
2018Q1 2025Q4
Shares held
12,700
Last filed at
Nov 14, 2025
Confidence Score
12.5
2025Q4
Confidence Score History
2025Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 8, 2025 Dec 10, 2025 Wave Life Sciences Ltd. Director Sell 7.5 -42,000 -76.78% ✓ $630K
Nov 13, 2025 Nov 14, 2025 Wave Life Sciences Ltd. Director Sell 10.0 -16,115 -55.93% ✓ $109.4K
Jan 17, 2025 Jan 17, 2025 Adaptimmune Therapeutics PLC CEO Sell 46.3 -30,601 -40.84% ✗ $17.8K
Jan 13, 2025 Jan 15, 2025 Adaptimmune Therapeutics PLC CEO Sell 46.3 -59,569 -41.18% ✗ $34.6K
Jan 16, 2024 Jan 17, 2024 Adaptimmune Therapeutics PLC CEO Sell 46.3 -39,384 -40.05% ✗ $27.6K
Jan 11, 2024 Jan 12, 2024 Adaptimmune Therapeutics PLC CEO Sell 46.3 -29,202 -39.47% ✗ $24.7K
Sep 1, 2023 Sep 1, 2023 Adaptimmune Therapeutics PLC CEO Sell 47.5 -2,403 -41.06% ✗ $1.9K
Jun 27, 2023 Jun 27, 2023 Adaptimmune Therapeutics PLC CEO Sell 47.5 -2,333 -39.87% ✗ $2.1K
Jan 17, 2023 Jan 17, 2023 Adaptimmune Therapeutics PLC CEO Sell 46.3 -10,057 -42.96% ✗ $18.7K
Jan 11, 2023 Jan 12, 2023 Adaptimmune Therapeutics PLC CEO Sell 42.5 -31,805 -42.99% ✗ $54.8K
Jan 4, 2023 Jan 4, 2023 Adaptimmune Therapeutics PLC CEO Sell 47.5 -5,073 -43.34% ✗ $8.6K
Sep 1, 2022 Sep 1, 2022 Adaptimmune Therapeutics PLC CEO Sell 47.5 -2,536 -43.34% ✗ $5K
Jun 27, 2022 Jun 27, 2022 Adaptimmune Therapeutics PLC CEO Sell 47.5 -2,562 -43.78% ✗ $4.2K
Jan 18, 2022 Jan 18, 2022 Adaptimmune Therapeutics PLC CEO Sell 46.3 -11,096 -47.40% ✗ $35.4K
Jan 11, 2022 Jan 13, 2022 Adaptimmune Therapeutics PLC CEO Sell 42.5 -17,408 -47.38% ✗ $61.9K
Jan 4, 2022 Jan 5, 2022 Adaptimmune Therapeutics PLC CEO Sell 46.3 -5,532 -47.27% ✗ $22.5K
Sep 1, 2021 Sep 1, 2021 Adaptimmune Therapeutics PLC CEO Sell 46.3 -2,782 -47.54% ✗ $14.5K
Jun 28, 2021 Jun 28, 2021 Adaptimmune Therapeutics PLC CEO Sell 46.3 -2,794 -47.74% ✗ $12.2K
Jan 19, 2021 Jan 19, 2021 Adaptimmune Therapeutics PLC CEO Sell 42.5 -9,879 -42.20% ✗ $56K
Jan 12, 2021 Jan 12, 2021 Adaptimmune Therapeutics PLC CEO Sell 46.3 -2,707 -42.28% ✗ $16.7K
Jan 4, 2021 Jan 5, 2021 Adaptimmune Therapeutics PLC CEO Sell 46.3 -4,967 -42.44% ✗ $26.5K
Sep 1, 2020 Sep 2, 2020 Adaptimmune Therapeutics PLC CEO Sell 46.3 -2,776 -47.44% ✗ $23.6K
Aug 3, 2020 Aug 4, 2020 Adaptimmune Therapeutics PLC CEO Sell 46.3 -2,788 -47.64% ✗ $25.8K
Jan 14, 2020 Jan 15, 2020 Adaptimmune Therapeutics PLC CEO Sell 46.3 -3,236 -50.55% ✗ $16.6K
Jan 6, 2020 Jan 7, 2020 Adaptimmune Therapeutics PLC CEO Sell 47.5 -5,900 -50.41% ✗ $7.1K
Jan 14, 2019 Jan 16, 2019 Adaptimmune Therapeutics PLC CFO Sell 46.3 -3,084 -48.17% ✗ $16.6K
Mar 20, 2018 Mar 22, 2018 Adaptimmune Therapeutics PLC CFO Sell 17.5 -600,000 -100.00% ✗ $1M